首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:International journal of cancer

缩写:INT J CANCER

ISSN:0020-7136

e-ISSN:1097-0215

IF/分区:4.7/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引11505
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Marta Maes-Carballo,Natalia de-la-Puente-Mota,Laura Sampol-Ramírez et al. Marta Maes-Carballo et al.
This systematic review synthesizes empirical evidence on the development, effectiveness, patient experience, and implementation of decision aids (DAs) for postmastectomy breast reconstruction (PMBR) and to evaluate the role of pre-consultat...
Shuang Huang,Ya-Qian Han,Kun-Yu Yang et al. Shuang Huang et al.
This prospective exploratory phase 2 study employed a three-cohort, two-phase design to evaluate the potential of anlotinib as a substitute for cisplatin in gemcitabine-penpulimab combinations for metastatic nasopharyngeal carcinoma (NPC) p...
Preethi Muthukumar,Lucy Shepherd,Sumayya Anwer et al. Preethi Muthukumar et al.
The relationship between radiological response and survival outcomes has been studied in upfront treatment in paediatric rhabdomyosarcoma and adult cancer settings. However, the extent of the relationship between these outcomes is unknown i...
Paola Armaroli,Marco Zappa,Paolo Giorgi Rossi et al. Paola Armaroli et al.
In Italy, the first women invited for HPV vaccination at 15-16 years reached the age for cervical screening (25 years) in 2018. The real-world vaccination impact was evaluated. Women born in 1993-1996 invited for organised cervical screenin...
Jieqiong Zhou,Wenqiang Yan,Yuntong Liu et al. Jieqiong Zhou et al.
Minimal residual disease (MRD) negativity is a well-established prognostic marker in multiple myeloma (MM), yet the clinical relevance of MRD response timing and duration remains unclear, particularly in real-world settings. We retrospectiv...
Monika Bar,Wiesława Widłak,Natalia Vydra Monika Bar
Breast cancer (BC) is the most commonly diagnosed tumor among women worldwide. Approximately 70% of cases are estrogen receptor-positive (ER+), whose growth is driven by estrogen signaling. Endocrine therapies targeting ER signaling are the...
Xueyuan Chen,Mengting Shi,Yuwen Yang et al. Xueyuan Chen et al.
SMARCA4-deficient thoracic tumor (SDTT) is a malignant tumor with a poor prognosis that often presents with distant metastases at the time of clinical diagnosis. Skeletal muscle metastasis is a rare subtype of metastasis patterns, and there...
W Ryan Diver,Lauren R Teras,Emily L Deubler et al. W Ryan Diver et al.
Outdoor air pollution, including particulate matter (PM), is a Group 1 carcinogen based on evidence for lung cancer; however, evidence for other cancers is limited. Further research on cancer incidence rather than mortality endpoints is nee...
Xionge Mei,Wei Wang,Nana Zheng et al. Xionge Mei et al.
Daytime light exposure is essential for health, primarily by synchronizing tissue and cellular-level clocks with the external light/dark cycle. Insufficient exposure may disrupt circadian alignment and contribute to adverse outcomes, includ...
Celina Ablinger,Petra Huber-Cantonati,Daniela D Weber et al. Celina Ablinger et al.
Approved in 2015 for radioiodine-refractory differentiated thyroid carcinoma (RR-DTC), the multikinase inhibitor lenvatinib has demonstrated substantial efficacy; nevertheless, severe adverse effects, intrinsic resistance or development of ...